Content uniformity is one of the most important release criteria for solid dosage forms. In pharmaceutical continuous manufacturing (PCM), what process analytical technologies (PAT) are available to measure and assure content uniformity as part of a real time release (RTR) strategy?
In a new article in Pharmaceutical Online, titled “Pharmaceutical Continuous Manufacturing: Content Uniformity with PAT & RTR,” Richard Steiner of Pharmatech Associates tackles that question and more. His paper discusses pharmaceutical continuous manufacturing (PCM) solutions and best practices to ensure content uniformity, applying QbD principles to achieve real time release testing — an opportunity for drug sponsors to simplify and reduce costs.
Pharmaceutical Online
https://www.pharmaceuticalonline.com/doc/pharmaceutical-continuous-manufacturing-content-uniformity-with-pat-and-rtr-0001
Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.
1.877.787.0177
510.732.0177
22320 Foothill Blvd. Suite 330, Hayward CA 94541